HR 3092

This bill, the Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025, aims to improve the quality of electrodiagnostic services covered by Medicare. It requires facilities offering nerve conduction studies and needle electromyography tests to be accredited by an organization approved by the Centers for Medicare & Medicaid Services (CMS), ensuring they meet specific quality control standards. The bill also establishes an advisory committee to help CMS develop these standards and combat fraud, with a phased-in implementation starting three years after enactment.